Видео ютуба по тегу Generic Drugs Forum

6th India Pharmaceutical Forum: Day 1 - Session 7 by Ms. Beata Stepniewska, Medicines for Europe
6th India Pharmaceutical Forum: Day 1 - Session 7 by Ms. Beata Stepniewska, Medicines for Europe
Deficiencies and Observations from Facility Evaluations and Inspections- FDA Generic Drug Forum 2019
Deficiencies and Observations from Facility Evaluations and Inspections- FDA Generic Drug Forum 2019
Filing and Refuse to Receive (RTR)- FDA Generic Drug Forum 2019
Filing and Refuse to Receive (RTR)- FDA Generic Drug Forum 2019
GDF 2024 | D1S02 - Office of Generic Drugs Keynote: Collaboration and Tools for Success
GDF 2024 | D1S02 - Office of Generic Drugs Keynote: Collaboration and Tools for Success
GDF2025 – D1S01 - Office of Generic Drugs (OGD) Keynote
GDF2025 – D1S01 - Office of Generic Drugs (OGD) Keynote
Assessment Tips (17of28) Generic Drugs Forum – Apr. 3-4, 2019
Assessment Tips (17of28) Generic Drugs Forum – Apr. 3-4, 2019
Using the ePortal to Submit a pre ANDA Meeting- FDA Generic Drug Forum 2018
Using the ePortal to Submit a pre ANDA Meeting- FDA Generic Drug Forum 2018
6th India Pharmaceutical Forum: CEO Panel Discussion: COVID-19 impact on Pharmaceutical Industry
6th India Pharmaceutical Forum: CEO Panel Discussion: COVID-19 impact on Pharmaceutical Industry
eCTD (7/28) Generic Drugs Forum 2017
eCTD (7/28) Generic Drugs Forum 2017
GDF2025 – D2S20 – Closing Remarks
GDF2025 – D2S20 – Closing Remarks
Case Studies: Inadequate Bioequivalence Studies (18of28) Generic Drugs Forum – Apr. 3-4, 2019
Case Studies: Inadequate Bioequivalence Studies (18of28) Generic Drugs Forum – Apr. 3-4, 2019
GDUFA II (9/28) Generic Drugs Forum 2017
GDUFA II (9/28) Generic Drugs Forum 2017
GDF2025 - D2S04 - Questions & Panel Discussion - Session One
GDF2025 - D2S04 - Questions & Panel Discussion - Session One
GDF2025 - D1S08 - Best Practices for Generic Drug Labeling
GDF2025 - D1S08 - Best Practices for Generic Drug Labeling
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access-Day 1, Pt 2
Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access-Day 1, Pt 2
GDUFA II Pre-ANDA Program Meetings: Advice for Success (10of27) Generic Drugs Forum 2018
GDUFA II Pre-ANDA Program Meetings: Advice for Success (10of27) Generic Drugs Forum 2018
GDUFA Regulatory Science Research Update (5/28) Generic Drugs Forum 2017
GDUFA Regulatory Science Research Update (5/28) Generic Drugs Forum 2017
Pre ANDA Interactions with the FDA 6of16 Generic Drugs Forum 2020
Pre ANDA Interactions with the FDA 6of16 Generic Drugs Forum 2020
Filing review basics Refuse to receive- FDA Generic Drug Forum 2018
Filing review basics Refuse to receive- FDA Generic Drug Forum 2018
The Benefits of Generic Drugs
The Benefits of Generic Drugs
Office of Pharmaceutical Quality (OPQ) Policy Update (4of27) Generic Drugs Forum April 2018
Office of Pharmaceutical Quality (OPQ) Policy Update (4of27) Generic Drugs Forum April 2018
Electronic Submissions- FDA Generic Drugs Forum 2018
Electronic Submissions- FDA Generic Drugs Forum 2018
ICH Q12 Guidance and Emerging Technology Program 11of16 Generic Drugs Forum 2020
ICH Q12 Guidance and Emerging Technology Program 11of16 Generic Drugs Forum 2020
XXI Pharmaceutical Forum in Saint-Petersburg
XXI Pharmaceutical Forum in Saint-Petersburg
Good ANDA Submission and Assessment Practices and Software Support- FDA Generic Drug Forum 2018
Good ANDA Submission and Assessment Practices and Software Support- FDA Generic Drug Forum 2018